Ticker ACCD – Accolade – sales, description, marketcap – Tickerday.com

ACCD

Accolade

–

Index: NASDAQ; Sector: Healthcare; Industry: Healthcare Facilities;

Marketcap: 1.73B; Volume: 253.22K; AvgVol 3m: 509.20K; Beta: –;

Cost estimate:

P/E: –; EPS: -2.43; EPS growth quarter/prev quarter: 3.40%;

EPS growth this year: 7.80%; EPS growth past 5 years: ;

EPS ttm: -2.46;

P/S: 15.05; P/B: ; P/Cashflow: 43.44; P/FCF: ;

Sales: 95.19M; Sales growth quarter/prev quarter: 41.40%; Sales growth past 5 years: ;

Profitability:

Gross Margin: 40.80%; Profit Margin: -49.60%; Operating Margin: -47.20%;

ROA – return on assets: ; ROE – return on equity: ; LT Debt/Equity: ; Total Debt/Equity: ;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 1.50%; Insider Transactions:0.00%;

Institutional Ownership: ; Institutional Transactions: ;

Data update: 07.10.2020.